Iris Melanoma — Clinical Trials

MONDO:00040642 activeLast updated: Mar 16, 2026, 12:42 AM

Iris Melanoma has an emerging clinical trial program, driven by drug treatment and biological therapy.

Recruiting

Active Trials

Drug Treatment2

Biological Therapy1

Phase 1

Phase 2

Academic/Other2

United States2 trials

Trials often recruit across multiple countries, so totals exceed the trial count.

2 Trials

Phase 2Active, Not Recruiting

Sponsor:Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University

United StatesStarted: Nov 2014Est. completion: Dec 2025Updated: Apr 2025

Phase 1Active, Not Recruiting

Sponsor:H. Lee Moffitt Cancer Center and Research Institute

United StatesStarted: Nov 2022Est. completion: Dec 2026Updated: Jan 2026

Stay informed about clinical trials for Iris Melanoma.

Follow this disease to get updates when trials open, close, or change status.

Already have an account? Sign in to manage your watchlists.

Data sourced from ClinicalTrials.gov via Kisho's automated pipeline. Trials refreshed every 4 hours for monitored diseases.

Last sync: March 16, 2026 at 12:42 AM